The safety and regulation of natural products used as foods and food ingredients.
暂无分享,去创建一个
C. Hilmas | R. P. Danam | E. Enongene | N. Anyangwe | T. Thurmond | Ali Abdel-Rahman | Louis Carlacci | Steve Casper | Rebecca P. Danam | Evaristus Enongene | Gladys Erives | Daniel Fabricant | Ramadevi Gudi | Fred Hines | Paul Howard | Dan Levy | Ying Lin | Robert J. Moore | Erika Pfeiler | Saleh Turujman | Nigel J. Walker
[1] M. Sanders,et al. The science and regulations of probiotic food and supplement product labeling , 2011, Annals of the New York Academy of Sciences.
[2] Joseph M. Betz,et al. Dietary supplement use in the United States, 2003-2006. , 2011, The Journal of nutrition.
[3] T. Dadd,et al. The impact of the catechol-O-methyltransferase genotype on the acute responsiveness of vascular reactivity to a green tea extract , 2010, British Journal of Nutrition.
[4] A. Chandra,et al. Goitrogenic/antithyroidal potential of green tea extract in relation to catechin in rats. , 2010, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[5] J. Heimbach,et al. Safety assessment of probiotics for human use , 2010, Gut microbes.
[6] R. Kuttan,et al. Beneficial effects of green tea: A literature review , 2010, Chinese medicine.
[7] E. Riedmann,et al. Exciting times for gastrointestinal microbiology , 2010, Gut microbes.
[8] E. Ernst,et al. Green tea (Camellia sinensis) for the prevention of cancer. , 2009, The Cochrane database of systematic reviews.
[9] G. Mazzanti,et al. Hepatotoxicity from green tea: a review of the literature and two unpublished cases , 2009, European Journal of Clinical Pharmacology.
[10] A. Thierry,et al. Safety assessment of dairy microorganisms: Propionibacterium and Bifidobacterium. , 2008, International journal of food microbiology.
[11] Sean M Hays,et al. Biomonitoring Equivalents (BE) dossier for 2,4-dichlorophenoxyacetic acid (2,4-D) (CAS No. 94-75-7). , 2008, Regulatory toxicology and pharmacology : RTP.
[12] G. Klein,et al. Safety aspects and implications of regulation of probiotic bacteria in food and food supplements. , 2008, Journal of food protection.
[13] F. Debellé,et al. Aristolochic acid nephropathy: a worldwide problem. , 2008, Kidney international.
[14] N. Brown,et al. Rebaudioside A: two-generation reproductive toxicity study in rats. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[15] Ashley Nicole Roberts,et al. Subchronic toxicity of rebaudioside A. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[16] J. Mckenney,et al. The hemodynamic effects of rebaudioside A in healthy adults with normal and low-normal blood pressure. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[17] A. Wheeler,et al. Pharmacokinetics of rebaudioside A and stevioside after single oral doses in healthy men. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[18] A. Renwick,et al. Comparative toxicokinetics and metabolism of rebaudioside A, stevioside, and steviol in rats. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[19] L. Barriocanal,et al. Apparent lack of pharmacological effect of steviol glycosides used as sweeteners in humans. A pilot study of repeated exposures in some normotensive and hypotensive individuals and in Type 1 and Type 2 diabetics. , 2008, Regulatory toxicology and pharmacology : RTP.
[20] A. Eapen,et al. A 90-Day Oral (Dietary) Toxicity Study of Rebaudioside A in Sprague-Dawley Rats , 2008, International journal of toxicology.
[21] B. Jelaković,et al. Role of environmental toxins in endemic (Balkan) nephropathy. October 2006, Zagreb, Croatia. , 2007, Journal of the American Society of Nephrology : JASN.
[22] M. Bernardeau,et al. Beneficial lactobacilli in food and feed: long-term use, biodiversity and proposals for specific and realistic safety assessments. , 2006, FEMS microbiology reviews.
[23] R. Isbrucker,et al. Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: dermal, acute and short-term toxicity studies. , 2006, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[24] Reyes Artacho,et al. Beneficial Effects of Green Tea—A Review , 2006, Journal of the American College of Nutrition.
[25] P. O'Brien,et al. Cellular and in vivo hepatotoxicity caused by green tea phenolic acids and catechins. , 2006, Free radical biology & medicine.
[26] D. Alberts,et al. Effects of Dosing Condition on the Oral Bioavailability of Green Tea Catechins after Single-Dose Administration of Polyphenon E in Healthy Individuals , 2005, Clinical Cancer Research.
[27] H. Babich,et al. In vitro cytotoxicity of epigallocatechin gallate and tea extracts to cancerous and normal cells from the human oral cavity. , 2004, Basic & clinical pharmacology & toxicology.
[28] Dietary Supplements Containing Ephedrine Alkaloids Adulterated Because They Present an Unreasonable Risk; Final Rule , 2004, Journal of pain & palliative care pharmacotherapy.
[29] B. Tomlinson,et al. Efficacy and tolerability of oral stevioside in patients with mild essential hypertension: a two-year, randomized, placebo-controlled study. , 2003, Clinical therapeutics.
[30] P. Vereerstraeten,et al. Progression rate of Chinese herb nephropathy: impact of Aristolochia fangchi ingested dose. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[31] C. DesRoches,et al. Americans' views on the use and regulation of dietary supplements. , 2001, Archives of internal medicine.
[32] M. Melis,et al. Effects of chronic administration of Stevia rebaudiana on fertility in rats. , 1999, Journal of ethnopharmacology.
[33] G. Lucier,et al. Medicinal herbs in the United States: research needs. , 1999, Environmental health perspectives.
[34] S. Musser,et al. Contamination of botanical dietary supplements by Digitalis lanata. , 1998, The New England journal of medicine.
[35] K. Toyoda,et al. Assessment of the carcinogenicity of stevioside in F344 rats. , 1997, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[36] Mélis Ms. A CRUDE EXTRACT OF STEVIA REBAUDIANA INCREASES THE RENAL PLASMA FLOW OF NORMAL AND HYPERTENSIVE RATS , 1996 .
[37] C. van Ypersele de Strihou,et al. Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. , 1996, Cancer research.
[38] M. Melis. Chronic administration of aqueous extract of Stevia rebaudiana in rats: renal effects. , 1995, Journal of ethnopharmacology.
[39] J L Vanherweghem,et al. Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[40] C van Ypersele de Strihou,et al. Chinese herbs nephropathy: a clue to Balkan endemic nephropathy? , 1994, Kidney international.
[41] J. Elford,et al. Psychology and survival , 1994, The Lancet.
[42] P. But,et al. Identification of aristolochic acid in Chinese herbs , 1994, The Lancet.
[43] M. Jadoul,et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs , 1993, The Lancet.
[44] J. Gleye,et al. Antibacterial activity of the leaves of Phyllanthus discoideus. , 1990, Journal of ethnopharmacology.
[45] J. Kuc,et al. Contraceptive Properties of Stevia rebaudiana , 1968, Science.
[46] Tribe De,et al. Choice of Diet by Rats , 1955, British Journal of Nutrition.
[47] V. Arlt,et al. Chemical and molecular basis of the carcinogenicity of Aristolochia plants. , 2009, Current opinion in drug discovery & development.
[48] G. Mahady,et al. Safety of Green Tea Extracts , 2008, Drug safety.
[49] A. von Wright. Regulating the safety of probiotics--the European approach. , 2005, Current pharmaceutical design.
[50] A. Vandewalle. Diversity within the CLC chloride channel family involved in inherited diseases: from plasma membranes to acidic organelles. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[51] A. Kinghorn,et al. Stevia: the genus Stevia. , 2002 .
[52] J. Vanherweghem,et al. Misuse of herbal remedies: the case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy) , 1998, Journal of alternative and complementary medicine.
[53] M. Melis. A crude extract of Stevia rebaudiana increases the renal plasma flow of normal and hypertensive rats. , 1996, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[54] EINZ,et al. UROTHELIAL CARCINOMA ASSOCIATED WITH THE USE OF A CHINESE HERB ( ARISTOLOCHIA FANGCHI ) , 2022 .